PCSA
Processa Pharmaceuticals, Inc.
1.96
1 x 2.18
1 x 2.48
bid
ask
+
0.04
2.08%
1 @ 08:53 AM
2.01 +0.05 (2.55%)
| Ytd | -31.94% | |
| 1y | -58.47% |
1.95
day range
2.15
1.76
52 week range
14.25
| Open | 1.99 | Prev Close | 1.92 | Low | 1.95 | High | 2.15 | Mkt Cap | 5.43M |
| Vol | 49.33K | Avg Vol | 64.81K | EPS | -4.07 | P/E | N/A | Forward P/E | -0.39 |
| Beta | 0.60 | Short Ratio | 2.45 | Inst. Own | 1.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.50 | 200-d Avg | 4.18 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 3.33M | ||
| Research and Development Expense | 1.81M | ||
| Selling, General and Administrative Expense | 1.52M | ||
| Operating Income | -3.33M | ||
| Net Income | -3.38M | ||
| Net Income Common Stock | -3.38M | ||
| Net Income Common Stock (USD) | -3.38M | ||
| Consolidated Income | -3.38M | ||
| Earnings per Basic Share | -1.29 | ||
| Earnings per Basic Share (USD) | -1.29 | ||
| Earnings per Diluted Share | -1.29 | ||
| Earning Before Interest & Taxes (EBIT) | -3.38M | ||
| Earning Before Interest & Taxes (USD) | -3.38M | ||
| Weighted Average Shares | 2.62M | ||
| Weighted Average Shares Diluted | 2.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.69M | ||
| Cash and Equivalents (USD) | 1.69M | ||
| Investments | 1.59M | ||
| Investments Non-Current | 1.59M | ||
| Current Assets | 1.94M | ||
| Property, Plant & Equipment Net | 3.51K | ||
| Total Assets | 4.52M | ||
| Current Liabilities | 1.98M | ||
| Total Liabilities | 1.98M | ||
| Accumulated Retained Earnings (Deficit) | -104.16M | ||
| Shareholders Equity | 2.54M | ||
| Shareholders Equity (USD) | 2.54M | ||
| Assets Non-Current | 2.58M | ||
| Trade and Non-Trade Payables | 840.37K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 301.00 | ||
| Net Cash Flow from Financing | 244.78K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.85M | ||
| Issuance (Purchase) of Equity Shares | 245.10K | ||
| Net Cash Flow from Investing | -500.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -500.00K | ||
| Net Cash Flow from Operations | -3.59M | ||
| Share Based Compensation | 95.96K | ||